FLOW CYTOMETRIC ASSAYS FOR MONITORING PRODUCTION OF RECOMBINANT HIV-1 GP160 IN INSECT CELLS INFECTED WITH A BACULOVIRUS EXPRESSION VECTOR

被引：7
|
作者：
FARMER, JL
HAMPTON, RG
BOOTS, E
机构：
来源：
JOURNAL OF VIROLOGICAL METHODS | 1989年 / 26卷 / 03期
关键词：
D O I：
10.1016/0166-0934(89)90110-9
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：279 / 290
页数：12
相关论文
共 50 条
  • [21] PRODUCTION OF HUMAN BETA INTERFERON IN INSECT CELLS INFECTED WITH A BACULOVIRUS EXPRESSION VECTOR
    SMITH, GE
    SUMMERS, MD
    FRASER, MJ
    MOLECULAR AND CELLULAR BIOLOGY, 1983, 3 (12) : 2156 - 2165
  • [22] PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160
    BERMAN, PW
    GREGORY, TJ
    RIDDLE, L
    NAKAMURA, GR
    CHAMPE, MA
    PORTER, JP
    WURM, FM
    HERSHBERG, RD
    COBB, EK
    EICHBERG, JW
    NATURE, 1990, 345 (6276) : 622 - 625
  • [23] LARGE-SCALE PRODUCTION AND PURIFICATION OF A VACCINIA RECOMBINANT-DERIVED HIV-1 GP160 AND ANALYSIS OF ITS IMMUNOGENICITY
    BARRETT, N
    MITTERER, A
    MUNDT, W
    EIBL, J
    EIBL, M
    GALLO, RC
    MOSS, B
    DORNER, F
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (02) : 159 - 171
  • [24] CLINICAL AND VIROLOGIC RESPONSES TO A RECOMBINANT VACCINIA HIV-1 GP160 VACCINE (HIVAC-1E)
    COREY, L
    COLLIER, A
    COOMBS, R
    ARDITTI, D
    HU, SL
    GREENBERG, P
    MCLAREN, C
    MARTIN, R
    DRAGAVON, J
    CHALOUPKA, K
    CLINICAL RESEARCH, 1989, 37 (02): : A562 - A562
  • [25] PRODUCTION OF LONG-LIVED NEUTRALIZING ANTIBODIES TO HIV-1 IIIB IN MICE WITH A VACCINIA RECOMBINANT VIRUS-INFECTED CELL VACCINE EXPRESSING GP160
    PARRY, C
    MCLAIN, L
    DIMMOCK, NJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (02) : 205 - 212
  • [26] HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) GP160-SPECIFIC LYMPHOCYTE PROLIFERATIVE RESPONSES OF MONONUCLEAR LEUKOCYTES FROM HIV-1 RECOMBINANT GP160 VACCINE RECIPIENTS
    KEEFER, MC
    BONNEZ, W
    ROBERTS, NJ
    DOLIN, R
    REICHMAN, RC
    JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03): : 448 - 453
  • [27] Phase I Clinical Trial with HIV-1 gp160 Plasmid Vaccine in HIV-1-Infected Asymptomatic Subjects
    R. Weber
    W. Bossart
    R. Cone
    R. Luethy
    K. Moelling
    European Journal of Clinical Microbiology & Infectious Diseases, 2001, 20 : 800 - 803
  • [28] Phase I clinical trial with HIV-1 gp160 plasmid vaccine in HIV-1-infected asymptomatic subjects
    Weber, R
    Bossart, W
    Cone, R
    Luethy, R
    Moelling, K
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (11) : 800 - 803
  • [29] FUNCTIONAL ROLES OF THE V3 HYPERVARIABLE REGION OF HIV-1 GP160 IN THE PROCESSING OF GP160 AND IN THE FORMATION OF SYNCYTIA IN CD4+ CELLS
    TRAVIS, BM
    DYKERS, TI
    HEWGILL, D
    LEDBETTER, J
    TSU, TT
    HU, SL
    LEWIS, JB
    VIROLOGY, 1992, 186 (01) : 313 - 317
  • [30] CHARACTERIZATION OF SERUM ANTIBODY-RESPONSES TO RECOMBINANT HIV-1 GP160 VACCINE BY ENZYME-IMMUNOASSAY
    VISCIDI, R
    ELLERBECK, E
    GARRISON, L
    MIDTHUN, K
    CLEMENTS, ML
    CLAYMAN, B
    FERNIE, B
    SMITH, G
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (11) : 1251 - 1256
12345